Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Radiomics 1 Prostatic Neoplasms 1 Pituitary Diseases 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neuroendocrine Tumors 1 Lung Neoplasms 1 Lung Diseases 1 Liver Cirrhosis 1 Hepatitis B 1 Head and Neck Neoplasms 1 Disease Progression 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Paclitaxel 13 pembrolizumab 8 Carboplatin 7 Surveys and Questionnaires 6 Cisplatin 6 Brachytherapy 5 Doxorubicin 4 Docetaxel 4 Pemetrexed 3 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 FANG vaccine 3 Biopsy 3 osimertinib 2 olaparib 2 niraparib 2 durvalumab 2 adavosertib 2 Trastuzumab 2 Topotecan 2 Taxes 2 Standard of Care 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Oxaliplatin 2 Nivolumab 2 Music Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Neoplasms × Radiomics × Clear all

NCT06963385 2025-05-09

ROME

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting

Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡